Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Eleonora, Arboscello"'
Autor:
Giacomo Vallome, Iacopo Cafaro, Annarita Bottini, Chiara Dellepiane, Giovanni Rossi, Elisa Bennicelli, Francesca Parisi, Lodovica Zullo, Marco Tagliamento, Alberto Ballestrero, Emanuela Barisione, Ines Maria Grazia Piroddi, Fabrizio Montecucco, Federico Carbone, Paolo Pronzato, Matteo Lambertini, Francesco Spagnolo, Giulia Barletta, Lucrezia Barcellini, Michele Ferrante, Simone Nardin, Simona Coco, Silvia Marconi, Linda Zinoli, Paolo Moscatelli, Eleonora Arboscello, Lucia Del Mastro, Andrea Bellodi, Carlo Genova
Publikováno v:
Heliyon, Vol 9, Iss 11, Pp e21177- (2023)
Background: Lung cancer patients diagnosed following emergency admission often present with advanced disease and poor performance status, leading to suboptimal treatment options and outcomes. This study aimed to investigate the clinical and molecular
Externí odkaz:
https://doaj.org/article/46d754b3a8b547b388883040cd0d56ad
Autor:
Giacomo Tini, Pietro Ameri, Giulia Buzzatti, Matteo Sarocchi, Roberto Murialdo, Giulia Guglielmi, Eleonora Arboscello, Alberto Ballestrero, Lucia Del Mastro, Paolo Spallarossa, Italo Porto
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 8 (2021)
Background: Women with breast cancer (BC) represent a special population particularly exposed to cardiovascular disease (CVD) risk. However, cardiologic assessment in BC is mostly limited to detection of left ventricular dysfunction cardiotoxicity (L
Externí odkaz:
https://doaj.org/article/e1d47f51519a4dfd865184cd64439abc
Autor:
Paolo Spallarossa, Matteo Sarocchi, Giacomo Tini, Eleonora Arboscello, Matteo Toma, Pietro Ameri, Italo Porto
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
Immune-checkpoint inhibitors (ICIs) represent a successful paradigm in the treatment of cancer. ICIs elicit an immune response directed against cancer cells, by targeting the so-called immune checkpoints, key regulators of the immune system that when
Externí odkaz:
https://doaj.org/article/e7c558fcb6374fa3b63d4fafae057e14
Autor:
Matteo Sarocchi, Matteo Bauckneht, Eleonora Arboscello, Selene Capitanio, Cecilia Marini, Silvia Morbelli, Maurizio Miglino, Angela Giovanna Congiu, Giorgio Ghigliotti, Manrico Balbi, Claudio Brunelli, Gianmario Sambuceti, Pietro Ameri, Paolo Spallarossa
Publikováno v:
Journal of Translational Medicine, Vol 16, Iss 1, Pp 1-8 (2018)
Abstract Background Doxorubicin (DOX)-based chemotherapy for Hodgkin lymphoma (HL) yields excellent disease-free survival, but poses a substantial risk of subsequent left ventricular (LV) dysfunction and heart failure, typically with delayed onset. A
Externí odkaz:
https://doaj.org/article/84f7163fb2d14e94bc8e90d43eac2675
Autor:
Amedeo Tirandi, Eleonora Arboscello, Stefano Ministrini, Luca Liberale, Aldo Bonaventura, Alessandra Vecchié, Maria Bertolotto, Daniele Roberto Giacobbe, Luca Castellani, Michele Mirabella, Silvia Minetti, Matteo Bassetti, Fabrizio Montecucco, Federico Carbone
Publikováno v:
Internal and Emergency Medicine.
Unmet needs challenge clinical management of sepsis especially concerning patient profiling, enhancing recovery, and long-term sequelae. Here, we preliminarily focused on sclerostin (SOST) as a candidate biomarker to encompass such a broad range of c
Autor:
Valentina Mercurio, Alessandra Cuomo, Christian Cadeddu Dessalvi, Martino Deidda, Daniela Di Lisi, Giuseppina Novo, Roberta Manganaro, Concetta Zito, Ciro Santoro, Pietro Ameri, Paolo Spallarossa, Eleonora Arboscello, Carlo Gabriele Tocchetti, Claudia Penna
Publikováno v:
Antioxidants, Vol 9, Iss 7, p 641 (2020)
Metabolic syndrome (MetS) is a well established risk factor for cardiovascular (CV) diseases. In addition, several studies indicate that MetS correlates with the increased risk of cancer in adults. The mechanisms linking MetS and cancer are not fully
Externí odkaz:
https://doaj.org/article/504debdf79ed4918a2ef91d29cac4f77
Autor:
Alessia Cavo, Alessandra Rubagotti, Elisa Zanardi, Chiara Fabbroni, Linda Zinoli, Antonio Di Meglio, Eleonora Arboscello, Andrea Bellodi, Paolo Spallarossa, Carlo Cattrini, Carlo Messina, Francesco Boccardo
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 10 (2018)
Background: The aim of this work was to to evaluate the incidence and risk factors of adverse events (AEs), focusing on cardiovascular events (CVEs) and hypokalemia, in patients treated with abiraterone acetate (AA) and prednisone (PDN) outside clini
Externí odkaz:
https://doaj.org/article/0fc20560a7454361bebefdf402326ced
Autor:
Chiara Russo, Luca Tagliafico, Laura Labate, Marta Ponzano, Michele Mirabella, Federica Portunato, Carmen Bellezza, Sara Mora, Eleonora Arboscello, Alessio Nencioni, Mauro Giacomini, Chiara Dentone, Matteo Bassetti
Publikováno v:
Open Forum Infectious Diseases. 9
Background Clinical trial demonstrated that SARS-CoV-2 vaccines have the ability of reduce mortality and morbidity due to COVID-19. The aim of this study is to describe the effect of vaccination in term of mortality, type of ventilation and ICU admis
Autor:
Giacomo Tini, Matteo Sarocchi, Pietro Ameri, Giuliano Tocci, Allegra Battistoni, Eleonora Arboscello, Paolo Spallarossa, Italo Porto
Publikováno v:
Journal of cardiovascular medicine (Hagerstown, Md.). 23(12)
Autor:
Stefano Sartini, Marzia Spadaro, Ombretta Cutuli, Luca Castellani, Marina Sartini, Maria Luisa Cristina, Paolo Canepa, Chiara Tognoni, Agnese Lo, Lorenzo Canata, Martina Rosso, Eleonora Arboscello
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 19; Pages: 5764
Antithrombotic therapy may affect outcomes in major trauma but its role is not fully understood. We aimed to investigate adverse outcomes among those with and without antithrombotic treatment in major trauma. Material and methods: This is a retrospec